BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 8622396)

  • 1. Cutaneous T-cell lymphoma (mycosis fungoides).
    Lorincz AL
    Lancet; 1996 Mar; 347(9005):871-6. PubMed ID: 8622396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cutaneous T-cell lymphoma].
    Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
    J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Pathologe; 2020 Feb; 41(1):79-94. PubMed ID: 31932947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.
    Whittaker SJ; Marsden JR; Spittle M; Russell Jones R; ;
    Br J Dermatol; 2003 Dec; 149(6):1095-1107. PubMed ID: 14696593
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi149-54. PubMed ID: 23868906
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
    Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
    Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Cedef
    Ann Dermatol Venereol; 2018 Mar; 145 Suppl 1():S186-S188. PubMed ID: 29475620
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma.
    Blom A; Beylot-Barry M; D'Incan M; Laroche L
    J Am Acad Dermatol; 2011 Aug; 65(2):404-410. PubMed ID: 21550694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T-cell lymphoma-Focus on some problems, and some solutions.
    Beltraminelli H
    Hematol Oncol; 2023 Jun; 41 Suppl 1():20-24. PubMed ID: 37294972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
    Bhabha FK; McCormack C; Wells J; Campbell BA; Newland K; Lade S; Buelens O; Joske D; Shortt J; Mapp S; Radeski D; Hertzberg M; Khot A; Van Der Weyden C; Khoo C; Hawkes E; Prince HM
    Australas J Dermatol; 2021 Feb; 62(1):e8-e18. PubMed ID: 33368169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Item no 164: malignant lymphoma: cutaneous lymphoma].
    CEDEF
    Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F160-2. PubMed ID: 18984207
    [No Abstract]   [Full Text] [Related]  

  • 15. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.
    Pruksaeakanan C; Teyateeti P; Patthamalai P; Thumrongtharadol J; Chairatchaneeboon M
    Biomed Res Int; 2021; 2021():4057661. PubMed ID: 34235215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics of mycosis fungoides and Sézary syndrome].
    Krc L; Dobesová J; Bucek M; Dusek J; Macák J; Galuszková D; Jurysek O
    Vnitr Lek; 1997 May; 43(5):285-9. PubMed ID: 9601850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycosis fungoides. Early diagnosis and evaluation of treatment by polymerase chain reaction].
    Aarset H; Skarsvåg S; Ryggen K
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3391-2. PubMed ID: 9411895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous T-cell lymphoma epidemiology: patients providing the power.
    Lessin SR
    Arch Dermatol; 2007 Jul; 143(7):916-8. PubMed ID: 17638738
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.